Related Experiment Video
Updated: May 20, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Efficacy of rituximab in dermatomyositis and polymyositis refractory to conventional therapy
Simón Ángel Sánchez-Fernández1, José Antonio Carrasco Fernández, Luisa Marena Rojas Vargas
1Sección de Reumatología, Hospital La Mancha Centro, Alcázar de San Juan, España. simon.sanchez.fernandez@gmail.com
Abstract:
We report one case of dermatomyositis and one of polymyositis refractory to several conventional inmunosupressive therapies, which present a response after treatment with rituximab, enabling steroid dose reduction and a prolonged remission.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies